Mirati Therapeutics Aktie
WKN DE: A1W1XV / ISIN: US60468T1051
17.03.2014 22:21:03
|
Mirati Therapeutics Q4 Loss Widens - Quick Facts
(RTTNews) - Mirati Therapeutics, Inc. (MRTX) said fourth-quarter net loss widened to $11.2 million or $0.97 per share from $6.3 million or $0.79 per share in the comparable quarter last year.
On average, three analysts polled by Thomson Reuters expected the company to report a loss of $0.66 per share. Analysts' estimates typically exclude special items.
Loss from operations widened to $7.9 million from $6.4 million in the prior year period.
Total operating expenses for the latest fourth quarter was $7.87 million, up from $6.35 million last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Mirati Therapeutics Incmehr Nachrichten
Keine Nachrichten verfügbar. |